COM:AGIOS
Agios Pharmaceuticals, Inc.
- Stock
Last Close
54.62
21/11 21:00
Market Cap
2.47B
Beta: -
Volume Today
360.45K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
net income | -39.41M - | -53.50M 35.77% | -117.73M 120.04% | -198.47M 68.58% | -314.67M 58.55% | -346.03M 9.97% | -411.47M 18.91% | -327.37M 20.44% | -356.51M 8.90% | -231.80M 34.98% | -352.09M 51.89% | |
depreciation and amortization | 1.44M - | 1.37M 5.07% | 3.34M 144.48% | 5.71M 70.80% | 6.43M 12.68% | 7.17M 11.50% | 8.09M 12.76% | 9.98M 23.46% | 9.24M 7.45% | 8.56M 7.32% | 6.62M 22.66% | |
deferred income tax | 3.84M - | -2.14M - | 3.02M 241.02% | -86.27M 2,954.83% | -77.93M - | |||||||
stock based compensation | 3.03M - | 11.51M 279.74% | 31.96M 177.79% | 42.09M 31.67% | 47.81M 13.60% | 73.36M 53.44% | 72.37M 1.34% | 75.12M 3.80% | 53.51M 28.77% | 49.30M 7.87% | 44.77M 9.19% | |
change in working capital | -25.59M - | -19.26M 24.73% | 4.91M 125.47% | 188.47M 3,741.54% | -24.83M 113.18% | -35.10M 41.37% | -46.00M 31.03% | -71.04M 54.43% | -36.82M 48.17% | -16.43M 55.37% | -19.06M 15.97% | |
accounts receivables | -6.02M - | -1.73M 71.19% | 3.34M 292.67% | 1.22M 63.58% | -6.10M 601.81% | -3.62M 40.69% | -10.06M 177.98% | -4.38M 56.48% | -2.21M 49.61% | -604K 72.62% | ||
inventory | 19K - | -3.17M 16,810.53% | 14.43M 554.61% | -2.08M 114.40% | -869K 58.18% | -6.46M 643.61% | -7.37M 14.00% | 4.38M 159.43% | -8.49M 293.97% | -10.58M 24.63% | ||
accounts payables | 30K - | 7.58M 25,156.67% | 4.21M 44.37% | 3.50M 16.94% | 5.33M 52.21% | -5.49M 202.98% | 3.72M 167.71% | 5.89M 58.48% | 1.86M 68.36% | 3.44M 84.43% | -8.73M 354.16% | |
other working capital | -25.62M - | -20.84M 18.65% | 5.60M 126.87% | 167.19M 2,886.10% | -29.30M 117.52% | -22.65M 22.71% | -39.63M 75.02% | -59.50M 50.12% | -38.69M 34.98% | -9.17M 76.29% | 864K 109.42% | |
other non cash items | 284K - | 538K 89.44% | 572K 6.32% | 773K 35.14% | 29K 96.25% | -3.82M 13,262.07% | 8.53M 323.53% | 19.52M 128.79% | 9.54M 51.14% | -119.10M 1,348.86% | 101.63M 185.33% | |
net cash provided by operating activities | -56.40M - | -59.35M 5.24% | -76.95M 29.65% | 38.56M 150.11% | -285.23M 839.67% | -304.42M 6.73% | -370.62M 21.75% | -290.76M 21.55% | -407.32M 40.09% | -309.48M 24.02% | -296.06M 4.34% | |
investments in property plant and equipment | -1.29M - | -2.22M 71.25% | -20.16M 809.93% | -9.91M 50.83% | -4.63M 53.33% | -6.99M 50.98% | -12.17M 74.22% | -14.91M 22.50% | -5.74M 61.49% | -4.88M 14.98% | -999K 79.53% | |
acquisitions net | -103.47M - | 803K 100.78% | 132.75M - | 1.32M 99.00% | ||||||||
purchases of investments | -146.05M - | -837.22M 473.25% | -353.18M 57.82% | -506.07M 43.29% | -688.70M 36.09% | -933.32M 35.52% | -488.57M 47.65% | -557.03M 14.01% | -1.38B 147.42% | -1.03B 25.21% | -417.93M 59.46% | |
sales maturities of investments | 60.13M - | 505.53M 740.78% | 501.65M 0.77% | 396.63M 20.93% | 635.42M 60.20% | 666.48M 4.89% | 592.18M 11.15% | 647.68M 9.37% | 829.80M 28.12% | 1.15B 38.13% | 674.68M 41.14% | |
other investing activites | 571K - | 103.47M - | -803K 100.78% | 1.80B 224,625.03% | 1 100.00% | -17.50M 1,750,000,100% | ||||||
net cash used for investing activites | -87.22M - | -333.34M 282.19% | 128.31M 138.49% | -119.35M 193.02% | -57.91M 51.48% | -273.82M 372.86% | 91.44M 133.39% | 75.75M 17.16% | 1.25B 1,548.64% | 243.26M 80.52% | 239.57M 1.52% | |
debt repayment | -113K - | -336K 197.35% | -578K 72.02% | -331K 42.73% | ||||||||
common stock issued | 126.12M - | 333.58M 164.50% | 162.15M - | 270.25M 66.67% | 516.21M 91.01% | 277.20M 46.30% | 11.32M 95.92% | 37.30M 229.56% | 2.68M 92.81% | 5.43M 102.65% | ||
common stock repurchased | -802.49M - | |||||||||||
dividends paid | -37.30M - | |||||||||||
other financing activites | -2.24M - | 1.58M 170.76% | 6.37M 302.59% | 7.63M 19.69% | 14.86M 94.81% | 29.82M 100.66% | 12.52M 58.00% | 250.54M 1,900.61% | 37.30M 85.11% | |||
net cash used provided by financing activities | 123.88M - | 335.16M 170.55% | 6.37M 98.10% | 169.78M 2,564.02% | 285.11M 67.93% | 546.02M 91.51% | 289.61M 46.96% | 261.52M 9.70% | -765.77M 392.82% | 2.35M 100.31% | 5.43M 131.19% | |
effect of forex changes on cash | ||||||||||||
net change in cash | -19.74M - | -57.53M 191.48% | 57.73M 200.35% | 88.99M 54.14% | -58.03M 165.21% | -32.22M 44.47% | 10.43M 132.37% | 46.51M 345.92% | 75.69M 62.76% | -63.87M 184.38% | -51.05M 20.06% | |
cash at beginning of period | 91.30M - | 71.56M 21.62% | 14.03M 80.39% | 71.76M 411.47% | 160.75M 124.00% | 102.72M 36.10% | 70.50M 31.37% | 80.93M 14.79% | 127.44M 57.46% | 203.13M 59.39% | 139.26M 31.44% | |
cash at end of period | 71.56M - | 14.03M 80.39% | 71.76M 411.47% | 160.75M 124.00% | 102.72M 36.10% | 70.50M 31.37% | 80.93M 14.79% | 127.44M 57.46% | 203.13M 59.39% | 139.26M 31.44% | 88.20M 36.66% | |
operating cash flow | -56.40M - | -59.35M 5.24% | -76.95M 29.65% | 38.56M 150.11% | -285.23M 839.67% | -304.42M 6.73% | -370.62M 21.75% | -290.76M 21.55% | -407.32M 40.09% | -309.48M 24.02% | -296.06M 4.34% | |
capital expenditure | -1.29M - | -2.22M 71.25% | -20.16M 809.93% | -9.91M 50.83% | -4.63M 53.33% | -6.99M 50.98% | -12.17M 74.22% | -14.91M 22.50% | -5.74M 61.49% | -4.88M 14.98% | -999K 79.53% | |
free cash flow | -57.69M - | -61.57M 6.72% | -97.11M 57.73% | 28.65M 129.50% | -289.86M 1,111.83% | -311.41M 7.43% | -382.79M 22.92% | -305.67M 20.15% | -413.06M 35.13% | -314.36M 23.90% | -297.06M 5.50% |
All numbers in (except ratios and percentages)